BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18051439)

  • 1. [Role of LXRs in control of lipogenesis].
    Kugimiya A; Takagi J; Uesugi M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1814-5. PubMed ID: 18051439
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of LXR alpha in goose primary hepatocyte lipogenesis.
    Han C; Wang J; Li L; Wang L; Zhang Z
    Mol Cell Biochem; 2009 Feb; 322(1-2):37-42. PubMed ID: 18975056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
    Cha JY; Repa JJ
    J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
    Qin Y; Dalen KT; Gustafsson JA; Nebb HI
    Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism mediating the activation of acetyl-coenzyme A carboxylase-alpha gene transcription by the liver X receptor agonist T0-901317.
    Talukdar S; Hillgartner FB
    J Lipid Res; 2006 Nov; 47(11):2451-61. PubMed ID: 16931873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
    Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
    Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X receptors control IgE expression in B cells.
    Heine G; Dahten A; Hilt K; Ernst D; Milovanovic M; Hartmann B; Worm M
    J Immunol; 2009 May; 182(9):5276-82. PubMed ID: 19380774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of liver X receptors in lipid accumulation in adipocytes.
    Juvet LK; Andresen SM; Schuster GU; Dalen KT; Tobin KA; Hollung K; Haugen F; Jacinto S; Ulven SM; Bamberg K; Gustafsson JA; Nebb HI
    Mol Endocrinol; 2003 Feb; 17(2):172-82. PubMed ID: 12554745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements.
    Cagen LM; Deng X; Wilcox HG; Park EA; Raghow R; Elam MB
    Biochem J; 2005 Jan; 385(Pt 1):207-16. PubMed ID: 15330762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study.
    Aravindhan K; Webb CL; Jaye M; Ghosh A; Willette RN; DiNardo NJ; Jucker BM
    J Lipid Res; 2006 Jun; 47(6):1250-60. PubMed ID: 16567856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
    J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha.
    Kim K; Kim KH; Kim HH; Cheong J
    Biochem J; 2008 Dec; 416(2):219-30. PubMed ID: 18782084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptors mediate inhibition of hCG secretion in a human placental trophoblast cell line.
    Weedon-Fekjaer MS; Duttaroy AK; Nebb HI
    Placenta; 2005 Nov; 26(10):721-8. PubMed ID: 16226121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SREBP-1-independent regulation of lipogenic gene expression in adipocytes.
    Sekiya M; Yahagi N; Matsuzaka T; Takeuchi Y; Nakagawa Y; Takahashi H; Okazaki H; Iizuka Y; Ohashi K; Gotoda T; Ishibashi S; Nagai R; Yamazaki T; Kadowaki T; Yamada N; Osuga J; Shimano H
    J Lipid Res; 2007 Jul; 48(7):1581-91. PubMed ID: 17456898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
    Mitro N; Vargas L; Romeo R; Koder A; Saez E
    FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand specificity and evolution of liver X receptors.
    Reschly EJ; Ai N; Welsh WJ; Ekins S; Hagey LR; Krasowski MD
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):83-94. PubMed ID: 18395439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
    Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
    J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.